Breast Cancer and Menopausal
New research in the Lancet shows a stronger connection between Menopausal Hormone Therapy (MHT) and Breast Cancer. The risks go up from the first day of going on MHT.
Harvard Medical School expert recommends a limit of only 1-2 years on MHT and then don’t just stop them, gradually lower the dosage
Women should try non-hormone strategies first before going on MHT. Vaginal estrogen is not an issue so can be used for longer periods of time.
Also, information included about giving all women with breast cancer genetic testing. Currently only those with a family history get it done.
It’s expected that it could save money in the long run by being able to provide better health care to those women